Responses

Download PDFPDF
Screening for syphilis during pregnancy in Nigeria: a practice that must continue
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Screening for syphilis during pregnancy in Nigeria: a practice that must continue
    • Abayomi A. Opaneye, Consultant Physician GU/HIV Medicine
    • Other Contributors:
      • A. Fabamwo, Consultant Obstetrician and Gynaecologist, Lagos State University Hospital, Ikeje.

    Dear Editor,

    Screening for syphilis during pregnancy in Nigeria: a practice that must continue We read with interest the report from Osogbo in Nigeria (1). In our opinion and experience, we agree that this practice should not only continue but be improved upon. In a similar study on pregnant women done in Lagos, Nigeria (2), the incidence of positive syphilis test was about 3%. Serology for other possible sexually trans...

    Show More
    Conflict of Interest:
    None declared.